Amy Scharf, MS, Louis Voigt, MD, Santosha Vardhana, MD, PhD, Konstantina Matsoukas, MLIS, Lisa M. Wall, PhD, RN, CNS, AOCNS, HEC-C, Maria Arevalo, RN, OCN, and Lisa C. Diamond, MD, MPH
Patients’ cultural, religious, and social norms deserve respect, but some decisions’ effects on patients’ outcomes can be unjust and ethically troubling.
AMA J Ethics. 2021;23(2):E97-108. doi:
10.1001/amajethics.2021.97.
A deep spirit of resilience and a desire for innovation, discovery, and justice compel health workers to retain their commitment to serving patients and communities.
AMA J Ethics. 2021;23(8):E662-665. doi:
10.1001/amajethics.2021.662.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Pringl Miller, MD, Preeti R. John, MD, MPH, and Sabha Ganai, MD, PhD, MPH
A surgeon’s duty is to identify goals of care, including those about quality of life, from a patient’s perspective and to consider how to achieve them.
AMA J Ethics. 2021;23(10):E778-782. doi:
10.1001/amajethics.2021.778.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"